Please wait while the formulary information is being retrieved.
TARCEVA (ERLOTINIB HCL)
- Adenocarcinoma of pancreas
- NSCLC with EGFR exon 19 deletion mutation
- NSCLC with EGFR exon 21 (l858r) substitution mutation
100 mg tablet
- 1 tablet (100 mg) by oral route once daily on an empty stomach, 1 hour before or 2 hours after a meal
150 mg tablet
- 1 tablet (150 mg) by oral route once daily on an empty stomach, 1 hour before or 2 hours after a meal
25 mg tablet
- 2 tablets (50 mg) by oral route once daily
100 mg tablet
- 1 tablet (100 mg) by oral route once daily on an empty stomach, 1 hour before or 2 hours after a meal
150 mg tablet
- 1 tablet (150 mg) by oral route once daily on an empty stomach, 1 hour before or 2 hours after a meal
25 mg tablet
- 2 tablets (50 mg) by oral route once daily
Adenocarcinoma of pancreas
- 2 tablets (50 mg) by oral route once daily
- 1 tablet (100 mg) by oral route once daily on an empty stomach, 1 hour before or 2 hours after a meal
NSCLC with EGFR exon 19 deletion mutation
- 2 tablets (50 mg) by oral route once daily
- 1 tablet (100 mg) by oral route once daily on an empty stomach, 1 hour before or 2 hours after a meal
- 1 tablet (150 mg) by oral route once daily on an empty stomach, 1 hour before or 2 hours after a meal
NSCLC with EGFR exon 21 (l858r) substitution mutation
- 2 tablets (50 mg) by oral route once daily
- 1 tablet (100 mg) by oral route once daily on an empty stomach, 1 hour before or 2 hours after a meal
- 1 tablet (150 mg) by oral route once daily on an empty stomach, 1 hour before or 2 hours after a meal
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- Acid Control (ranitidine)
- Acid Controller
- Acid Controller Complete
- Acid Reducer (cimetidine)
- Acid Reducer (famotidine)
- Acid Reducer (ranitidine)
- Acid Reducer Complete (famot)
- Acid Relief (cimetidine)
- Aciphex
- Aciphex Sprinkle
- amoxicil-clarithromy-lansopraz
- B cplx-C-St.Johnwrt-K.&S.ginsg
- Belladonna-phenobarbital
- calcium-mag-B complex-D3-hrb61
- carbamazepine
- Carbatrol
- Cerebyx
- cimetidine
- Cold & Flu Fighter
- Complete
- Deprizine
- dexamethasone
- Dexamethasone Intensol
- dexamethasone sodium phos (PF)
- dexamethasone sodium phosphate
- Dexilant
- dexlansoprazole
- Dexpak 10 Day
- Dexpak 13 Day
- Dexpak 6 Day
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- Donnatal
- Dual Action Complete
- Duexis
- enzalutamide
- Epitol
- Equetro
- esomeprazole magnesium
- esomeprazole sodium
- esomeprazole strontium
- famotidine
- famotidine (PF)
- famotidine (PF)-NaCl (iso-os)
- famotidine-Ca carb-mag hydrox
- Fatigue Relief Complex
- First-lansoprazole
- First-omeprazole
- fosphenytoin
- Heartburn Prevention
- Heartburn Relief
- Heartburn Relief (famotidine)
- Heartburn Relief (ranitidine)
- Heartburn Relief 24 Hour
- Heartburn Treatment 24 Hour
- ibuprofen-famotidine
- isoniazid-rifamp-pyrazinamide
- lansoprazole
- Luminal
- Mycobutin
- Mysoline
- naproxen-esomeprazole
- Nexium
- Nexium Iv
- Nexium Packet
- nizatidine
- Omeclamox-pak
- omeprazole
- omeprazole magnesium
- Omeprazole+syrspend Sf Alka
- omeprazole-clarith-amoxicillin
- omeprazole-sodium bicarbonate
- pantoprazole
- Pepcid
- Pepcid Ac
- Pepcid Complete
- phenobarb-hyoscy-atropine-scop
- phenobarbital
- phenobarbital sodium
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- Prevacid
- Prevacid 24Hr
- Prevacid Solutab
- Prevpac
- Prilosec
- Prilosec Otc
- primidone
- Protonix
- rabeprazole
- ranitidine HCl
- rifabutin
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- Rifater
- St. John's wort
- Tagamet Hb
- Tegretol
- Tegretol Xr
- Tums Dual Action
- Vimovo
- vit C-St. John wort-elder-hb30
- Wal-zan 150
- Women's Complex
- Xtandi
- Zantac
- Zantac Maximum Strength
- Zegerid
- Zegerid Otc
Severe
Moderate
- A-hydrocort
- A-methapred
- Abraxane
- Acid Gone
- Acid Gone Antacid
- activated charcoal-calcium car
- Advanced Antacid-antigas
- Advil
- Advil Allergy Sinus
- Advil Allergy-congestion Rlf
- Advil Cold & Sinus
- Advil Congestion Relief
- Advil Liqui-gel
- Advil Migraine
- Advil Pm
- Advil Pm Liqui-gels
- Al hyd-Mg tr-alg ac-sod bicarb
- Alcalak
- Aleve
- Aleve Cold & Sinus
- Aleve Sinus & Headache
- Aleve-d Sinus & Cold
- Aleve-d Sinus & Headache
- Alferon N
- All Day Pain Relief
- All Day Pain Relief Sinus & Co
- All Day Relief
- Almacone
- Almacone-2
- alum-mag hydroxide-simeth
- aluminum hydrox-magnesium carb
- aluminum hydroxide gel
- aluminum-magnesium hydroxide
- Anaprox
- Anaprox Ds
- Ansaid
- Antacid
- Antacid Anti-gas
- Antacid Anti-gas Double Str
- Antacid Calcium
- Antacid Extra Strength
- Antacid Extra-strength
- Antacid Ii Plus Simethicone
- Antacid Liquid
- Antacid M
- Antacid Maximum Strength
- Antacid Multi-symptom
- Antacid Plus Anti-gas
- Antacid Plus Extra Strength
- Antacid Regular Strength
- Antacid Supreme
- Antacid Tablet
- Antacid Ultra Strength
- Antacid With Simethicone
- Antacid-antigas
- Antacid-antigas Ii
- Antacid-simethicone
- Antacid-simethicone Ds
- Anucort-hc
- Anusol-hc
- Aristospan Intra-articular
- Aristospan Intralesional
- Arthrotec 50
- ASA-acetaminophen-caff-buffers
- aspirin, buffered
- aspirin-calcium carbonate
- Avastin
- Bayer Plus Extra Strength
- betamethasone acet & sod phos
- bevacizumab
- budesonide
- Buffered Aspirin
- Bufferin
- cal phos-mag hydrx-C & D3-phos
- Cal-gest Antacid
- calcium & magnesium carbonates
- Calcium Antacid
- Calcium Antacid Tropical
- Calcium Antacid Ultra Max St
- calcium carb-mag hydrox-simeth
- calcium carbonate
- calcium carbonate-mag hydroxid
- calcium-simethicone
- Caldolor
- Cambia
- Cataflam
- Celebrex
- celecoxib
- Celestone Soluspan
- Child Ibuprofen
- Children's Advil
- Children's Ibu-drops
- Children's Ibuprofen
- Children's Medi-profen
- Children's Motrin
- Children's Pepto
- Children's Profen Ib
- Children's Soothe
- chlorphen-phenyleph-ibuprofen
- chlorphen-pseudoeph-ibuprofen
- Cold & Sinus Pain Relief
- Cold-sinus Relief
- Colocort
- Comfort Gel
- Comfort Gel Extra Strength
- Cortef
- Cortenema
- Cortifoam
- cortisone
- Coumadin
- Daypro
- Depo-medrol
- diclofenac epolamine
- diclofenac potassium
- diclofenac sodium
- diclofenac submicronized
- diclofenac-misoprostol
- diosmin complex no.1
- Docefrez
- docetaxel
- Ec-naprosyn
- Entocort Ec
- etodolac
- Ez Use Joint-tunnel-trigger
- Feldene
- fenoprofen
- First-duke's
- First-mary's Mouthwash
- Flanax
- Flector
- Flo-pred
- fludrocortisone
- flurbiprofen
- Foaming Antacid
- Foaming Antacid Extra Strength
- Gaviscon
- Gaviscon Extra Strength
- Gelusil Antacid & Anti-gas
- Geri-lanta
- Geri-mox Antacid-antigas
- Grx Hicort 25
- Heartburn Antacid
- Hemril-30
- hydrocodone-ibuprofen
- hydrocortisone
- hydrocortisone acetate
- hydrocortisone sod succ (PF)
- hydrocortisone sod succinate
- I-prin
- Ibu-drops
- Ibudone
- ibuprofen
- Ibuprofen Cold
- Ibuprofen Cold-sinus(with Pse)
- Ibuprofen Ib
- Ibuprofen Jr Strength
- ibuprofen lysine (PF)
- Ibuprofen Pm
- ibuprofen-diphenhydramine
- ibuprofen-diphenhydramine HCl
- ibuprofen-oxycodone
- ibuprofen-phenylephrine HCl
- Indocin
- indomethacin
- indomethacin sodium
- Infant's Ibuprofen
- Infant's Medi-profen
- Infant's Motrin
- Infants Ibu-drops
- Infants Profenib
- Infergen
- interferon alfa-2b
- interferon alfa-n3
- interferon alfacon-1
- Intron A
- itraconazole
- Jantoven
- Kenalog
- ketoconazole
- ketoprofen
- ketorolac
- Liquid Antacid
- Maalox Advanced
- Maalox Maximum Strength
- Mag-al
- Mag-al Plus
- Mag-al Plus Extra Strength
- magaldrate
- magaldrate-simethicone
- Maglox
- magnesium hydroxide
- magnesium-aluminum-alginic ac
- Masanti Double Strength
- Medi-profen
- Mediproxen
- Medrol
- Medrol (pak)
- mefenamic acid
- meloxicam
- methylprednisolone
- methylprednisolone acetate
- methylprednisolone sod suc(PF)
- methylprednisolone sodium succ
- methylprednisolone-bupivacaine
- Mi-acid
- Midol (naproxen)
- Milk Of Magnesia
- Milk Of Magnesia Concentrated
- Millipred
- Millipred Dp
- Mintox
- Mintox Maximum Strength
- Mintox Plus
- Mobic
- Motrin Ib
- Motrin Pm
- nabumetone
- Nalfon
- Naprelan Cr
- Naprosyn
- naproxen
- naproxen sodium
- naproxen-pseudoephedrine
- Neoprofen (ibuprofen Lysn)(pf)
- nystatin-hydrocortisone-diphen
- nystatin-TCN-HC-diphenhydramin
- Ob Complete One
- Onmel
- Onxol
- Orapred
- Orapred Odt
- oxaprozin
- paclitaxel
- paclitaxel-protein bound
- Pedia-lax
- Pediapred
- Pegasys
- Pegasys Convenience Pack
- Pegasys Proclick
- peginterferon alfa-2a
- peginterferon alfa-2b
- Pegintron
- Pegintron Redipen
- Pennsaid
- Phillips Milk Of Magnesia
- Physicians Ez Use M-pred
- piroxicam
- PN85-iron cb&asp g-FA-dha-fish
- Ponstel
- prednisolone
- prednisolone acetate
- prednisolone sodium phosphate
- prednisone
- Prednisone Intensol
- Pro-cal
- Proctocort
- Provil
- pseudoephedrine-ibuprofen
- Rayos
- Rectacort-hc
- Reprexain
- Ri-gel
- Ri-gel Ii
- Ri-mag
- Ri-mag Plus
- Ri-mox
- Ri-mox Plus
- Riginic
- Rulox
- Sinus & Cold-d
- Smooth Antacid
- Solaraze
- Solu-cortef
- Solu-cortef (pf)
- Solu-medrol
- Solu-medrol (pf)
- Sporanox
- Sporanox Pulsepak
- Sprix
- sulindac
- Supreme Antacid
- Sylatron
- Sylatron 4-pack
- Taxotere
- tolmetin
- Toxin Control
- Tri-buffered Aspirin
- triamcinolone acetonide
- triamcinolone hexacetonide
- triamcinolone-lidocaine
- Tums
- Tums E-x
- Tums Extra Strength Smoothies
- Tums Freshers
- Tums Ultra
- Uceris
- Ultra Strength Antacid
- Ultra Strength Calcium Antacid
- Vanquish
- Vasculera
- Veripred 20
- Vfend
- Vfend Iv
- Vicoprofen
- Voltaren-xr
- voriconazole
- Wal-profen
- Wal-profen Cold-sinus
- Wal-proxen
- warfarin
- Women's Aspirin With Calcium
- Zipsor
- Zorvolex
- Lactating mother
Contraindicated
- Abnormal hepatic function tests
- Acute myocardial infarction
- Acute respiratory distress syndrome
- Dehydration
- Disease of liver
- Gastrointestinal perforation
- Hemolytic anemia
- Hepatorenal syndrome
- Hyperbilirubinemia
- Interstitial lung disease
- Interstitial pneumonitis
- Kidney disease with likely reduction in GFR
- Malignant neoplasm of liver
- Myocardial ischemia
- Pregnancy
- Pulmonary fibrosis
- Thrombocytopenic disorder
- Thrombotic thrombocytopenic purpura
- Tobacco smoker
Severe
Moderate
- Cerebrovascular accident
- Corneal ulcer
- Hemorrhage
- Hypokalemia
- Increased risk of bleeding due to coagulation disorder
TARCEVA (ERLOTINIB HCL)
- Adenocarcinoma of pancreas
- NSCLC with EGFR exon 19 deletion mutation
- NSCLC with EGFR exon 21 (l858r) substitution mutation
- Dyspnea
- Infection
- Skin rash
- Anorexia
- Cough
- Diarrhea
- Dry skin
- Fatigue
- Nausea
- Vomiting
More Frequent
Severe
Less Severe
- Conjunctivitis
- Keratoconjunctivitis sicca
- Stomatitis
- Arthralgias
- Hypertrichosis of eyelid eyelashes
- Myalgias
- Pruritus of skin
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute myocardial infarction
- Acute renal failure
- Bullous dermatitis
- Cerebrovascular accident
- Colitis
- Corneal ulcer
- Exfoliative dermatitis
- Gastrointestinal hemorrhage
- Gastrointestinal perforation
- Hepatic failure
- Hepatorenal syndrome
- Hyperbilirubinemia
- Interstitial lung disease
- Kidney disease with reduction in GFR
- Myopathy
- Perforation of cornea
- Pulmonary infiltrates
- Rhabdomyolysis
- Stevens-johnson syndrome
- Thrombocytopenic disorder
- Thrombotic thrombocytopenic purpura
- Toxic epidermal necrolysis
- Uveitis
Less Severe
- Hirsutism
- Nail disorders
- Skin pigmentation enhancement
Contraindicated
None
Severe Precaution
Erlotinib
No established efficacy in pediatrics in trials for recurrent or refractory ependymoma.
- 1 Day – 18 Years
- No established efficacy in pediatrics in trials for recurrent or refractory ependymoma.
Management or Monitoring Precaution
None
Erlotinib
- Severity Level:
D
- Additional Notes: Mfr recommends contraception during therapy and 2 wks after therapy is completed
Contraindicated
Erlotinib
Insuff data avail; pot for serious toxicity
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Insuff data avail; pot for serious toxicity |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Erlotinib
General-Dehydration increases risk of renal failure. Monitor electrolytes and renal function.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | Y | Y | N | Y | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Adenocarcinoma of pancreas | |
| C24.1 | Malignant neoplasm of ampulla of vater |
| C25 | Malignant neoplasm of pancreas |
| C25.0 | Malignant neoplasm of head of pancreas |
| C25.1 | Malignant neoplasm of body of pancreas |
| C25.2 | Malignant neoplasm of tail of pancreas |
| C25.3 | Malignant neoplasm of pancreatic duct |
| C25.4 | Malignant neoplasm of endocrine pancreas |
| C25.7 | Malignant neoplasm of other parts of pancreas |
| C25.8 | Malignant neoplasm of overlapping sites of pancreas |
| C25.9 | Malignant neoplasm of pancreas, unspecified |
| NSCLC with EGFR exon 19 deletion mutation | |
| C34 | Malignant neoplasm of bronchus and lung |
| C34.0 | Malignant neoplasm of main bronchus |
| C34.00 | Malignant neoplasm of unspecified main bronchus |
| C34.01 | Malignant neoplasm of right main bronchus |
| C34.02 | Malignant neoplasm of left main bronchus |
| C34.1 | Malignant neoplasm of upper lobe, bronchus or lung |
| C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
| C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
| C34.3 | Malignant neoplasm of lower lobe, bronchus or lung |
| C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
| C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
| C34.8 | Malignant neoplasm of overlapping sites of bronchus and lung |
| C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
| C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
| C34.9 | Malignant neoplasm of unspecified part of bronchus or lung |
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
| C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
| NSCLC with EGFR exon 21 (l858r) substitution mutation | |
| C34 | Malignant neoplasm of bronchus and lung |
| C34.0 | Malignant neoplasm of main bronchus |
| C34.00 | Malignant neoplasm of unspecified main bronchus |
| C34.01 | Malignant neoplasm of right main bronchus |
| C34.02 | Malignant neoplasm of left main bronchus |
| C34.1 | Malignant neoplasm of upper lobe, bronchus or lung |
| C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
| C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
| C34.3 | Malignant neoplasm of lower lobe, bronchus or lung |
| C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
| C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
| C34.8 | Malignant neoplasm of overlapping sites of bronchus and lung |
| C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
| C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
| C34.9 | Malignant neoplasm of unspecified part of bronchus or lung |
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
| C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
| 0-9 | A-Z |
|---|---|
| C24.1 | Malignant neoplasm of ampulla of vater |
| C25 | Malignant neoplasm of pancreas |
| C25.0 | Malignant neoplasm of head of pancreas |
| C25.1 | Malignant neoplasm of body of pancreas |
| C25.2 | Malignant neoplasm of tail of pancreas |
| C25.3 | Malignant neoplasm of pancreatic duct |
| C25.4 | Malignant neoplasm of endocrine pancreas |
| C25.7 | Malignant neoplasm of other parts of pancreas |
| C25.8 | Malignant neoplasm of overlapping sites of pancreas |
| C25.9 | Malignant neoplasm of pancreas, unspecified |
| C34 | Malignant neoplasm of bronchus and lung |
| C34 | Malignant neoplasm of bronchus and lung |
| C34.0 | Malignant neoplasm of main bronchus |
| C34.0 | Malignant neoplasm of main bronchus |
| C34.00 | Malignant neoplasm of unspecified main bronchus |
| C34.00 | Malignant neoplasm of unspecified main bronchus |
| C34.01 | Malignant neoplasm of right main bronchus |
| C34.01 | Malignant neoplasm of right main bronchus |
| C34.02 | Malignant neoplasm of left main bronchus |
| C34.02 | Malignant neoplasm of left main bronchus |
| C34.1 | Malignant neoplasm of upper lobe, bronchus or lung |
| C34.1 | Malignant neoplasm of upper lobe, bronchus or lung |
| C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C34.10 | Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
| C34.11 | Malignant neoplasm of upper lobe, right bronchus or lung |
| C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
| C34.12 | Malignant neoplasm of upper lobe, left bronchus or lung |
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
| C34.2 | Malignant neoplasm of middle lobe, bronchus or lung |
| C34.3 | Malignant neoplasm of lower lobe, bronchus or lung |
| C34.3 | Malignant neoplasm of lower lobe, bronchus or lung |
| C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C34.30 | Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
| C34.31 | Malignant neoplasm of lower lobe, right bronchus or lung |
| C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
| C34.32 | Malignant neoplasm of lower lobe, left bronchus or lung |
| C34.8 | Malignant neoplasm of overlapping sites of bronchus and lung |
| C34.8 | Malignant neoplasm of overlapping sites of bronchus and lung |
| C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C34.80 | Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
| C34.81 | Malignant neoplasm of overlapping sites of right bronchus and lung |
| C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
| C34.82 | Malignant neoplasm of overlapping sites of left bronchus and lung |
| C34.9 | Malignant neoplasm of unspecified part of bronchus or lung |
| C34.9 | Malignant neoplasm of unspecified part of bronchus or lung |
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C34.90 | Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C34.91 | Malignant neoplasm of unspecified part of right bronchus or lung |
| C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
| C34.92 | Malignant neoplasm of unspecified part of left bronchus or lung |
| C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
| C39.9 | Malignant neoplasm of lower respiratory tract, part unspecified |
Formulary Reference Tool